Zobrazeno 1 - 10
of 837
pro vyhledávání: '"David A. Morrow"'
Autor:
Ryan R. Keane, MD, Anthony P. Carnicelli, MD, Daniel B. Loriaux, MD, Payton Kendsersky, MD, Richard A. Krasuski, MD, Kelly M. Brown, BSN, Kelly Arps, MD, Vivian Baird-Zars, MPH, Jeffrey A. Dixson, MD, Emily Echols, Christopher B. Granger, MD, Robert W. Harrison, MD, Michael Kontos, MD, L. Kristin Newby, MD, MHS, Jeong-Gun Park, PhD, Kevin S. Shah, MD, Bradley W. Ternus, MD, Sean Van Diepen, MD, Jason N. Katz, MD, MHS, David A. Morrow, MD, MPH
Publikováno v:
JACC: Advances, Vol 3, Iss 8, Pp 101077- (2024)
Background: Little is known regarding the characteristics, treatment patterns, and outcomes in patients with adult congenital heart disease (ACHD) admitted to cardiac intensive care units (CICUs). Objectives: The authors sought to better define the c
Externí odkaz:
https://doaj.org/article/9474f3dacc684e14afffae8bb9651e71
Autor:
Jacob C. Jentzer, Sean Van Diepen, Parag C. Patel, Timothy D. Henry, David A. Morrow, David A. Baran, Kianoush B. Kashani
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 23 (2023)
Background One‐time assessment of the Society for Cardiovascular Angiography and Interventions (SCAI) shock classification robustly predicts mortality in the cardiac intensive care unit (CICU). We sought to determine whether serial SCAI shock class
Externí odkaz:
https://doaj.org/article/518581a89c664b328e184a028f50882a
Autor:
Yasser M. Sammour, John A. Spertus, Kevin Kennedy, David A. Morrow, Lori B. Daniels, Phil Jones, Heather Alger, Laura Stevens, Alpesh Shah, Sachin S. Goel, James A. de Lemos, Salim S. Hayek, Nadia R. Sutton, Neal S. Kleiman
Publikováno v:
American Heart Journal Plus, Vol 27, Iss , Pp 100265- (2023)
Background: Elevated cardiac troponin (cTn) levels in patients with COVID-19 has been associated with worse outcomes. Guidelines on best practices of those patients remain uncertain. Methods: We included patients with COVID-19 and cTn above the assay
Externí odkaz:
https://doaj.org/article/ad068b3a4d9442c88db2edf128ecbcaf
Autor:
Ankeet S. Bhatt, Anubodh S. Varshney, Erica L. Goodrich, Jingyi Gong, Curtis Ginder, Balimkiz C. Senman, Matthew Johnson, Kayleigh Butler, Ann E. Woolley, James A. de Lemos, David A. Morrow, Erin A. Bohula
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 9 (2022)
Background Early reports from the COVID‐19 pandemic identified coronary thrombosis leading to ST‐segment–elevation myocardial infarction (STEMI) as a complication of COVID‐19 infection. However, the epidemiology of STEMI in patients with COVI
Externí odkaz:
https://doaj.org/article/ecc44afeefd44bb6b450edbe35f89fa8
Autor:
Martin Aguilar, MD, PhD, Allison L. Tsao, MD, Kevin J. Croce, MD, PhD, William Sauer, MD, FHRS, David A. Morrow, MD, MPH, Usha B. Tedrow, MD, MSc, FHRS
Publikováno v:
HeartRhythm Case Reports, Vol 6, Iss 2, Pp 72-76 (2020)
Externí odkaz:
https://doaj.org/article/87276296b5a54b87bb16ab63c34bd4e4
Autor:
Christian O’Donnell, Melanie D. Ashland, Elena C. Vasti, Ying Lu, Andrew Y. Chang, Paul Wang, Lori B. Daniels, James A. de Lemos, David A. Morrow, Fatima Rodriguez, Connor G. O’Brien
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 24 (2021)
Background Currently, there is limited research on the prognostic value of NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) as a biomarker in COVID‐19. We proposed the a priori hypothesis that an elevated NT‐proBNP concentration at a
Externí odkaz:
https://doaj.org/article/b587f962077242068dfa5e64ec36b235
Autor:
David D. Berg, Benjamin L. Freedman, Marc P. Bonaca, Petr Jarolim, Benjamin M. Scirica, Erica L. Goodrich, Marc S. Sabatine, David A. Morrow
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 9 (2021)
Background Patients with stable atherothrombotic disease vary in their risk of developing heart failure (HF). Circulating cardiovascular biomarkers may improve HF risk assessment and identify patients who may benefit from emerging HF preventive thera
Externí odkaz:
https://doaj.org/article/6e3d75915fc5499bb2bf69f456300b41
Autor:
Thomas A. Zelniker, David A. Morrow, Benjamin M. Scirica, Jeremy D. Furtado, Jianping Guo, Dariush Mozaffarian, Marc S. Sabatine, Michelle L. O’Donoghue
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 8 (2021)
Background Plasma omega‐3 polyunsaturated fatty acids (ω3‐PUFAs) have been shown to be inversely correlated with the risk of cardiovascular death in primary prevention. The risk relationship in the setting of an acute coronary syndrome is less w
Externí odkaz:
https://doaj.org/article/d797898b86ee493aa2561be02d9b7c75
Autor:
Brian A. Bergmark, David A. Morrow
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/8b83c93d657347b281fec5115b442107
Autor:
Cian P. McCarthy, Sean Murphy, Maeve Jones-O'Connor, David S. Olshan, Jay R. Khambhati, Saad Rehman, John B. Cadigan, Jinghan Cui, Eric A. Meyerowitz, George Philippides, Lawrence S. Friedman, Aran Y. Kadar, Kathryn Hibbert, Pradeep Natarajan, Anthony F. Massaro, Erin A. Bohula, David A. Morrow, Ann E. Woolley, James L. Januzzi, Jr, Jason H. Wasfy
Publikováno v:
EClinicalMedicine, Vol 26, Iss , Pp 100504- (2020)
Background: Despite over 4 million cases of novel coronavirus disease 2019 (COVID-19) in the United States, limited data exist including socioeconomic background and post-discharge outcomes for patients hospitalized with this disease. Methods: In thi
Externí odkaz:
https://doaj.org/article/65ac3dd0b9554300968f33319df3e317